PICS LifeSign smoking cessation computer research receives $750,000 Phase II NCI grant.
This article was originally published in The Tan Sheet
Executive Summary
PICS LIFESIGN SMOKING CESSATION COMPUTER AWARDED NCI PHASE II GRANT for continued research of the product's use in conjunction with OTC nicotine replacement gum, Reston, Va.-based Personal Improvement Computer Systems announced Sept. 30. The company received the $750,000 grant from the National Cancer Institute on Sept. 15 following its completion of a Phase I study of LifeSign, also funded by NCI. Both awards were given under NCI's Small Business Innovation Research awards program.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning